JENNIFER ROSSI-STEPHENS: Open Payments
NPI 1912569120 · EAST PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$865 in 40 payments from 14 companies in 2025. Trend: 2023 $400 · 2024 $422 · 2025 $865
Food & beverage: $865
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $430 |
| Novo Nordisk Inc | 3 | $65 |
| Neurocrine BioSciences, Inc. | 2 | $53 |
| Biogen, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Mannkind Corporation | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Exact Sciences Corporation | 1 | $25 |
Products named: VRAYLAR, UBRELVY, QULIPTA, INGREZZA, SKYCLARYS, MOUNJARO, Wegovy, Kerendia.
Industry payments across RI — which companies pay providers there.
